Keyphrases
Coactivator
100%
Sirtuin 1 (SIRT1)
100%
PARP-1 Inhibitor
100%
Diabetic Heart
100%
Proliferator-activated Receptor-γ
100%
Angiotensin II (Ang II)
71%
PARP Inhibitor (PARPi)
42%
Oxidative Stress
28%
Inflammation
28%
Fibrosis
28%
Glucose Level
28%
Diabetic Mice
28%
Cardiomyocytes
28%
Cardiomyopathy
28%
DNA Repair
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Binding Protein
14%
Obesity
14%
Heart Failure
14%
In Vitro Experiment
14%
Negatively Charged
14%
Nicotinamide Adenine Dinucleotide (NAD+)
14%
Transcriptional Regulation
14%
Hypertension
14%
Protein Expression
14%
Diabetic
14%
Inflammatory Markers
14%
ROS Production
14%
Energy Metabolism
14%
Post-translational Modification
14%
Antioxidant System
14%
Leptin
14%
Nuclear Proteins
14%
Chromatin Remodeling
14%
In Vivo Test
14%
Peroxisome Proliferator-activated Receptor
14%
ADP-ribose
14%
Myocardial Remodeling
14%
EX-527
14%
Intracellular Trafficking
14%
Impaired Glucose Tolerance
14%
Db Mouse
14%
Cardiac Hypertrophy
14%
Neonatal Rat Cardiomyocytes
14%
SIRT Inhibitor
14%
Diabetic Cardiomyopathy
14%
PARP (poly(ADP-ribose) polymerase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Sirtuin 1
100%
Mouse
83%
Angiotensin II
83%
Ino 1001
66%
Diabetes Mellitus
50%
Inflammation
33%
Fibrosis
33%
Cardiomyopathy
33%
Non Insulin Dependent Diabetes Mellitus
16%
Db/Db Mouse
16%
Heart Failure
16%
Tumor Necrosis Factor
16%
Heart Ventricle Hypertrophy
16%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
16%
Peroxisome Proliferator Activated Receptor Gamma
16%
Antioxidant
16%
Nuclear Protein
16%
Impaired Glucose Tolerance
16%
Leptin
16%
Adenosine Diphosphate Ribose
16%
Diabetic Cardiomyopathy
16%